Pharmaceuticals, Biotechnology and Life Sciences
NEW YORK–(BUSINESS WIRE)–Woolsey Pharmaceuticals announced today that it completed a license agreement with Japanese pharmaceutical company Asahi Kasei Pharma Corporation,…
Ceremony to host Bonnie Bassler, molecular biologist and microbe fighter; Robert J. Hariri, stem cell and human longevity expert; and…
DUBLIN–(BUSINESS WIRE)–The “Stem Cell Banking Market by Source, by Application, and by Service Type: Global Industry Perspective, Comprehensive Analysis, and…
— STK-001 is a potential new disease-modifying medicine for the treatment of Dravet syndrome, a severe and progressive form of…
LOS ANGELES–(BUSINESS WIRE)–AccendoWave, the leading NON-PHARMACEUTICAL OPIOID ALTERNATIVE, is bringing its clinically proven opioid alternative to patients at home with…
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Tricida, Inc. (Nasdaq: TCDA) today announced that it will present at the Evercore ISI 2nd Annual…
SEATTLE–(BUSINESS WIRE)–#Azacitidine–According to Coherent Market Insights, the global myelodysplastic syndrome treatment market was valued at US$ 2,324.8 million in 2018,…
Demonstrates Growing Interest and Demand for Alternatives to Plasmids as Source of DNA in Pre-Clinical Therapeutic Applications STONY BROOK, N.Y.–(BUSINESS…
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–#INDstatus–PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therapies for cancer and diabetes…
Funding represents 51st CARB-X Award, and 2nd CARB-X Award for VenatoRx BOSTON, Mass. & MALVERN, Penn.–(BUSINESS WIRE)–#antibiotics–CARB-X is awarding VenatoRx…